Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity
ABSTRACTPurpose:To evaluate 2-year outcomes following intravitreal bevacizumab (IVB) as monotherapy for aggressive posterior retinopathy of prematurity (APROP).Methods:Medical records of 40 infants were retrospectively reviewed. Group I included infants who had received IVB injections for APROP. Gro...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Conselho Brasileiro de Oftalmologia
2015-10-01
|
Series: | Arquivos Brasileiros de Oftalmologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492015000550079&lng=en&tlng=en |